Article
Recrudescence, Reinfection, or Relapse? A More Rigorous Framework to Assess Chloroquine Efficacy for Plasmodium vivax Malaria.
The Journal of infectious diseases - 7 Jan 2019
Popovici Jean, Pierce-Friedrich Lindsey, Kim Saorin, Bin Sophalai, Run Vorleak, Lek Dysoley, Hee Kim Hor Daryl, Lee Soon-U Lawrence, Cannon Matthew V, Serre David, Menard Didier
Abstract excerpt
Background: Plasmodium vivax resistance to chloroquine (CQ) has been reported worldwide, although the World Health Organization clinical drug efficacy studies protocol does not permit classification of patient outcomes. Methods: We enrolled 40 patients with P. vivax malaria in northeastern Cambodia, where >17% treatment failures were previously reported. Patients were treated with CQ (30 mg/kg) and followed for 2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
